Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled, Forced Dose-escalation, Multi-center Pilot Study to Evaluate the Lipid Regulating Effects of TRIA-662 (1-methylnicotinamide Chloride)

NCT02008084 is registered in ClinicalTrials.gov with Cortria Corporation as lead sponsor.

NCT NCT02008084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02008084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled, Forced Dose-escalation, Multi-center Pilot Study to Evaluate the Lipid Regulating Effects of TRIA-662 (1-methylnicotinamide Chloride)
Lead sponsor
Cortria Corporation
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2013
Completion date
October 31, 2015
Enrollment
71 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

hypertriglyceridemia, mixed hyperlipidemia